- Home
- ASR vs QGEN Comparison
ASR vs QGEN Comparison
Compare ASR & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASR
- QGEN
- Stock Information
- Founded
- ASR 1996
- QGEN 1986
- Country
- ASR Mexico
- QGEN Netherlands
- Employees
- ASR N/A
- QGEN N/A
- Industry
- ASR Aerospace
- QGEN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ASR Consumer Discretionary
- QGEN Health Care
- Exchange
- ASR Nasdaq
- QGEN Nasdaq
- Market Cap
- ASR 9.7B
- QGEN 10.8B
- IPO Year
- ASR 2000
- QGEN 1996
- Fundamental
- Price
- ASR $301.29
- QGEN $50.22
- Analyst Decision
- ASR Hold
- QGEN Buy
- Analyst Count
- ASR 1
- QGEN 8
- Target Price
- ASR $310.00
- QGEN $50.68
- AVG Volume (30 Days)
- ASR 72.3K
- QGEN 1.5M
- Earning Date
- ASR 07-22-2025
- QGEN 08-05-2025
- Dividend Yield
- ASR 7.68%
- QGEN 3.00%
- EPS Growth
- ASR 3.79
- QGEN N/A
- EPS
- ASR 2.20
- QGEN 0.42
- Revenue
- ASR $1,803,288,586.00
- QGEN $2,002,874,000.00
- Revenue This Year
- ASR $15.63
- QGEN $6.41
- Revenue Next Year
- ASR $10.41
- QGEN $5.70
- P/E Ratio
- ASR $13.81
- QGEN $118.76
- Revenue Growth
- ASR 21.26
- QGEN 3.31
- 52 Week Low
- ASR $248.88
- QGEN $37.63
- 52 Week High
- ASR $360.00
- QGEN $51.88
- Technical
- Relative Strength Index (RSI)
- ASR 45.12
- QGEN 55.37
- Support Level
- ASR $298.19
- QGEN $49.16
- Resistance Level
- ASR $305.56
- QGEN $51.39
- Average True Range (ATR)
- ASR 7.63
- QGEN 0.78
- MACD
- ASR 0.03
- QGEN -0.11
- Stochastic Oscillator
- ASR 41.71
- QGEN 48.58
About ASR Grupo Aeroportuario del Sureste S.A. de C.V.
Grupo Aeroportuario del Sureste SAB de CV and its subsidiaries hold concessions to operate, maintain, and develop airports in the southeast region of Mexico. As an operator of airports, it charges airlines, passengers, and other users fees for using the airports' facilities. The group also derives rental and other income from commercial activities conducted at its airports, such as the leasing of space to restaurants and retailers. The group's operating segments are Cancun, which generates maximum revenue, Aerostar, Airplan, Merida, Villahermosa, Holding and Services, and Others.
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2023 sales), followed by EMEA (32%), and the Asia-Pacific (16%).